198 related articles for article (PubMed ID: 24821172)
1. Statin-associated acute interstitial nephritis and rhabdomyolysis.
Panchangam V
Saudi J Kidney Dis Transpl; 2014 May; 25(3):659-60. PubMed ID: 24821172
[No Abstract] [Full Text] [Related]
2. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine.
Castro JG; Gutierrez L
Am J Med; 2002 Apr; 112(6):505. PubMed ID: 11959068
[No Abstract] [Full Text] [Related]
4. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
Cannon CS
JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
[No Abstract] [Full Text] [Related]
5. [Rhabdomyolysis associated to combined ezetimibe-statin treatment].
Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA
Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879
[No Abstract] [Full Text] [Related]
6. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
Lewin JJ; Nappi JM; Taylor MH
Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
[TBL] [Abstract][Full Text] [Related]
7. Hypernatremia due to rhabdomyolysis in a patient on statin.
Victor SM; Gnanaraj A; Abraham G; Sankardas MA
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1037-8. PubMed ID: 21912045
[No Abstract] [Full Text] [Related]
8. [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy].
Rubí S; Duch J; Ortín J; Setoain X; Pons F
Rev Esp Med Nucl; 2006; 25(6):393. PubMed ID: 17173790
[No Abstract] [Full Text] [Related]
9. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Golomb B; Evans M
Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465
[No Abstract] [Full Text] [Related]
10. Rhabdomyolysis with atorvastatin and fusidic acid.
O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
[TBL] [Abstract][Full Text] [Related]
11. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
[No Abstract] [Full Text] [Related]
12. Unexpected observation of glomerular crescents in a patient with diabetes who developed drug-induced acute tubulointerstitial nephritis: A possible feature of diabetic nephropathy?
Wakabayashi N; Takeda S; Imai T; Akimoto T; Nagata D
Nephrology (Carlton); 2015 Jun; 20(6):438-9. PubMed ID: 25900387
[No Abstract] [Full Text] [Related]
13. [Metabolic rhabdomyolysis during statin therapy].
Vergely N; Leca V; Antoine JC; Germain N; Khalfallah Y; Estour B
Rev Med Interne; 2009 Aug; 30(8):711-3. PubMed ID: 19419805
[TBL] [Abstract][Full Text] [Related]
14. Pooled RCTs: atorvastatin did not increase renal-related serious adverse events.
Herrington W; Haynes R
Ann Intern Med; 2014 Oct; 161(8):JC8. PubMed ID: 25329225
[No Abstract] [Full Text] [Related]
15. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
Maltz HC; Balog DL; Cheigh JS
Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
[TBL] [Abstract][Full Text] [Related]
16. Intensive lipid lowering with atorvastatin in coronary disease.
Ravnskov U; Rosch PJ; Sutter MC
N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834
[No Abstract] [Full Text] [Related]
17. Statin-associated rhabdomyolysis: is there a dose-response relationship?
Holbrook A; Wright M; Sung M; Ribic C; Baker S
Can J Cardiol; 2011; 27(2):146-51. PubMed ID: 21459261
[TBL] [Abstract][Full Text] [Related]
18. A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis.
Noordally SO; Sohawon S; Vanderhulst J; Duttmann R; Corazza F; Devriendt J
Ann Saudi Med; 2012; 32(3):309-11. PubMed ID: 22588445
[TBL] [Abstract][Full Text] [Related]
19. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Ronaldson KJ; O'Shea JM; Boyd IW
Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
